These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1015201)

  • 1. Cefazolin in the treatment of biliary tract infections.
    Paulet P
    Acta Gastroenterol Belg; 1976; 39(7-8):293-7. PubMed ID: 1015201
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
    Pedretti G; Magnani G
    G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cefazolin--review and clinical experiences].
    Grief S; Forche G
    Wien Med Wochenschr; 1976 Aug; 126(32-35):497-9. PubMed ID: 793196
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibiotics in the treatment of biliary tract infections].
    Perkowski H
    Wiad Lek; 1989 Jan; 42(2):101-5. PubMed ID: 2683383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy for biliary tract infection (XXXIII). Tissue concentration of NY-198 in gallbladder, biliary excretion and clinical effects].
    Tanimura H; Aoki Y; Uesaka K; Kasano Y; Nakai T; Kitamura T; Mukaihara S; Tamura K; Yotsumoto F; Terao R
    Nihon Geka Hokan; 1988 Sep; 57(5):381-99. PubMed ID: 3251425
    [No Abstract]   [Full Text] [Related]  

  • 6. [Notes on a clinical trial of a new antibiotic: cefazolin].
    Bolgan A
    Minerva Nefrol; 1975; 22(6):327-30. PubMed ID: 1233012
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of cefoxitin sodium and cefazolin.
    Gurwith M; Albritton W; Lank B; Harding G; Ronald A
    J Antimicrob Chemother; 1978 Jul; 4(B):211-3. PubMed ID: 357389
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with a new cephalosporin: cefazolin. Preliminary experience].
    Castagueto HE; Groppo EA; Lipszyc PR; Mazzini O
    Rev Clin Esp; 1976 Jan; 140(2):171-6. PubMed ID: 1251071
    [No Abstract]   [Full Text] [Related]  

  • 9. [A clinical evaluation of the efficacy of using Zanocin (ofloxacin) in surgery].
    Saenko VF; Viktorov AP; Golopykho LI; Nichitaĭlo ME; Gorshevikova EV
    Klin Khir; 1995; (9-10):18-9. PubMed ID: 8697205
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S; Abe H; Bekki E; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Watanabe Y
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical studies with cefazolin: a new cephalosporin antibiotic.
    Hammer GS; Ribner BS; Meyers BR; Hirschman SZ
    Mt Sinai J Med; 1975; 42(2):142-9. PubMed ID: 1079566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cefazolin content in the gall bladder (author's transl)].
    Greif S; Forche G; Kratochvil P
    Wien Klin Wochenschr; 1977 Feb; 89(3):89-90. PubMed ID: 836611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kefzol in prophylactic treatment of orthopedic patients. Retrospective study with ampicillin].
    Iarchy J; Cockx E
    Acta Orthop Belg; 1976; 42(6):543-9. PubMed ID: 1030574
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the clinical effect of ceftezole (Falomesin 'Chugai') in respiratory- and urinary-tract infections (author's transl)].
    Arai S; Takishima T; Kosaka S; Kanazawa T; Takahashi H; Hamajima A; Nishimura H; Yoshida T; Tamura T; Usui Y; Takasugi R; Iwabuchi T; Ise T; Ishii M; Tadokoro K; Matsumoto N; Sato S; Saito K; Sato T; Kudo K; Mori S; Shimanuki K; Ito K; Ishihara T; Maeda T; Tsuiki K; Takahashi K; Kimura H; Saito K; Ishikawa H; Kanehara A
    Jpn J Antibiot; 1978 Nov; 31(11):625-32. PubMed ID: 731858
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cefazolin--pharmacokinetics and clinical effectiveness in urinary tract infections].
    Peters HJ; Daiss W; Wundt W; Nuri M
    Med Welt; 1975 Jul; 26(27-28):1331-4. PubMed ID: 1100982
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
    Karachalios GN; Nasiopoulou DD; Bourlinou PK; Reppa A
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):555-7. PubMed ID: 8996852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsuccessful treatment of staphylococcal endocarditis with cefazolin.
    Bryant RE; Alford RH
    JAMA; 1977 Feb; 237(6):569-70. PubMed ID: 576284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)].
    Abe H; Hirasawa S; Bekki E; Sawada Y; Hashimoto I; Nakamura T; Mikami J; Katoh H; Matsuda S
    Jpn J Antibiot; 1981 Apr; 34(4):631-40. PubMed ID: 6457172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefazolin (Kefzol, Eli Lilly) and Cefazolin (Astra)].
    Kampmann JP
    Ugeskr Laeger; 1975 Jan; 137(5):284. PubMed ID: 1136040
    [No Abstract]   [Full Text] [Related]  

  • 20. A double blind clinical trial of cefotaxime and cefazolin in complicated urinary tract infections.
    Ohkawa M; Kuroda K
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():231-3. PubMed ID: 6252162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.